Clinical Trials Logo

Joint Diseases clinical trials

View clinical trials related to Joint Diseases.

Filter by:

NCT ID: NCT00599248 Completed - Clinical trials for Osteoarthritis, Knee

Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee

TGC-03-01
Start date: January 2007
Phase: Phase 1
Study type: Interventional

The study is being conducted to investigate the safety and activity of TissueGene-C injected into the knee joint of patients with chronic degenerative joint disease (DJD) who will be undergoing total knee replacement.

NCT ID: NCT00589108 Completed - Clinical trials for Degenerative Joint Disease

Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty

Start date: January 2001
Phase: N/A
Study type: Interventional

Pain, weakness, instability, and progressive dysfunction are the hallmarks of arthritis of the knee. Total knee replacement may frequently be the only therapeutic intervention to provide adequate improvement in pain and function. Both fixed bearing and mobile bearing knees have a long track record of clinical success. Mobile bearing designs have theoretical advantages of decreased contact stresses on the tibial tray, decreased polyethylene wear, and improved range of motion relative to fixed bearing designs. These theoretical advantages may become especially important in the young patient who requires a knee arthroplasty. This study will attempt to see if there is a clinical difference in outcome between mobile bearing and fixed bearing knee arthroplasties in patients who require total knee replacement.

NCT ID: NCT00564980 Terminated - Joint Disease Clinical Trials

PRCT: Comparing Two Procedures for Ulno-Carpal Abutment Syndrome.

UAS
Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate two different currently accepted surgical treatments for UAS (ulnocarpal abutment syndrome). The hypothesis is that ulnar shortening osteotomy procedure will be associated with longer surgical time and increased complication rate when compared to the wafer procedure. It is unclear as to whether there will be a difference in functional outcome between the two groups.

NCT ID: NCT00561600 Completed - Clinical trials for Non-inflammatory Degenerative Joint Disease

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

ASR
Start date: November 2006
Phase: N/A
Study type: Interventional

The primary objective of this investigation is to evaluate the clinical and radiographic outcomes of the ASR™-XL Acetabular Cup System compared to the Pinnacle™ Acetabular Cup with a 28mm or 36mm ULTAMET™ metal insert.

NCT ID: NCT00546598 Terminated - Osteoarthritis Clinical Trials

Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System

Start date: January 1, 2006
Phase: Phase 4
Study type: Interventional

This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.

NCT ID: NCT00471393 Completed - Clinical trials for Temporomandibular Degenerative Joint Disease

Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease

Start date: May 2006
Phase: N/A
Study type: Interventional

The use of a topical medication was compared to placebo to be applied over the symptomatic temporomandibular joint in women with the diagnosis of osteoarthritis of the temporomandibular joint(s). The hypothesis is to investigate whether the use of a topical anti-inflammatory medication when compared to the placebo would decrease the pain of the affected joint and/or increased mouth opening.

NCT ID: NCT00303056 Completed - Joint Disease Clinical Trials

Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis

Start date: February 2006
Phase: Phase 2
Study type: Interventional

The primary objective is to compare the overall treatment effect on pain relief between icatibant and placebo. The secondary objectives are to assess the efficacy of icatibant in term of onset, extent and duration of pain relief relative to triamcinolone, to evaluate the safety of icatibant, to evaluate overall conditions of daily life after treatment with icatibant, to assess systemic exposure of icatibant following intra-articular injection.

NCT ID: NCT00245960 Completed - Psoriatic Arthritis Clinical Trials

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

Start date: December 27, 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study was to compare the efficacy of 2 different Etanercept regimens for the treatment of skin and joint manifestations of psoriatic arthritis.

NCT ID: NCT00237042 Completed - Clinical trials for Temporomandibular Joint Disorders

Managing Temporomandibular Disorder (TMD) Symptoms

Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.

NCT ID: NCT00223353 Completed - Joint Disease Clinical Trials

Quantitative Gait Analysis for Clinical Decision Making

Start date: November 1998
Phase: N/A
Study type: Observational

The overall purpose of this study is to develop an improved gait analysis system for the real time acquisition, calculation and interpretation of joint kinematic and kinetic information using linked segment body model animation to display and visually depict deviations from normal motion and joint function. Patients referred to the laboratory for clinical gait analysis are invited to participate in the project. If interested, subjects are informed by a study investigator of the study goals, procedures, risks and any benefits. A study investigator is responsible for obtaining informed consent. Data from normal subjects are used to establish a normative database. Data from other subjects contributes to the relevant databases of different disorders.